Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-03-037217
Filing Date
2003-11-13
Accepted
2003-11-13 14:36:51
Documents
6
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2122418z10-q.htm 10-Q 235961
3 EXHIBIT 10.1 a2122418zex-10_1.htm EX-10.1 29287
4 EXHIBIT 10.2 a2122418zex-10_2.htm EX-10.2 3692
5 EXHIBIT 31.1 a2122418zex-31_1.htm EX-31.1 5144
6 EXHIBIT 31.2 a2122418zex-31_2.htm EX-31.2 5137
7 EXHIBIT 32.1 a2122418zex-32_1.htm EX-32.1 2879
  Complete submission text file 0001047469-03-037217.txt   284165
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 03997442
SIC: 2834 Pharmaceutical Preparations